Institute for Aging Research, Hebrew SeniorLife, Boston, MA 02131, USA.
Osteoporos Int. 2010 Jan;21(1):53-60. doi: 10.1007/s00198-009-1127-3.
We applied the 2008 National Osteoporosis Foundation (NOF) Guidelines to Framingham Osteoporosis Study participants and found nearly one half of Caucasian postmenopausal women and one sixth of men aged 50 years and older would be recommended for osteoporosis treatment. Given the high proportion of persons recommended for treatment, NOF Guidelines may need to be re-evaluated with respect to budget impact.
Little is known about the public health impact of the NOF Guidelines. Therefore, we determined the proportion of US Caucasians recommended for treatment of osteoporosis according to NOF Guidelines (2003 and 2008).
One thousand nine hundred and forty-six postmenopausal women and 1,681 men aged > or =50 years from the Framingham Study with information on bone mineral density (1987-2001) were included. Information on clinical predictors was used to estimate the 10-year probability of hip and major osteoporotic fracture by FRAX (version 3.0).
Overall proportion of women meeting treatment criterion was less when the 2008 NOF Guidelines were applied (41.1%) compared with 2003 Guidelines (47.8%). The proportion of women aged <65 years meeting treatment criterion was much less when applying 2008 Guidelines (23.1% in 2003, 8.3% in 2008), whereas the proportion of women aged >75 years increased slightly (78.3% in 2003, 86.0% in 2008). Seventeen percent of men aged > or =50 years met treatment criterion (2.5% aged 50-64 years, 49.8% aged >75 years).
Nearly one half of Caucasian postmenopausal women and one sixth of men aged 50 years and older would be recommended for osteoporosis treatment according to 2008 NOF Guidelines. Given the high proportion of persons recommended for treatment, NOF Guidelines may need to be re-evaluated with respect to budget impact.
我们将 2008 年国家骨质疏松基金会 (NOF) 指南应用于弗雷明汉骨质疏松研究参与者,发现近一半的白种人绝经后妇女和六分之一的 50 岁及以上男性将被推荐进行骨质疏松治疗。鉴于推荐治疗的人数比例很高,NOF 指南可能需要重新评估其对预算的影响。
对于 NOF 指南的公共卫生影响知之甚少。因此,我们根据 NOF 指南(2003 年和 2008 年)确定了美国白种人接受骨质疏松治疗的比例。
纳入了 1946 名绝经后妇女和 1681 名年龄> =50 岁的男性,这些人来自弗雷明汉研究,且有骨密度信息(1987-2001 年)。使用 FRAX(版本 3.0)来估计 10 年内髋部和主要骨质疏松性骨折的临床预测因子的概率。
与 2003 年指南相比,2008 年 NOF 指南应用时女性符合治疗标准的比例较低(41.1%比 47.8%)。应用 2008 年指南时,年龄<65 岁的女性符合治疗标准的比例要低得多(2003 年为 23.1%,2008 年为 8.3%),而年龄>75 岁的女性比例略有增加(2003 年为 78.3%,2008 年为 86.0%)。17%的年龄> =50 岁的男性符合治疗标准(50-64 岁年龄组为 2.5%,>75 岁年龄组为 49.8%)。
根据 2008 年 NOF 指南,近一半的白种人绝经后妇女和六分之一的 50 岁及以上男性将被推荐进行骨质疏松治疗。鉴于推荐治疗的人数比例很高,NOF 指南可能需要重新评估其对预算的影响。